268 related articles for article (PubMed ID: 34740994)
21. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
Yu H; Wu Y; Huang J; Li S
Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
[TBL] [Abstract][Full Text] [Related]
22. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
23. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.
Peng Y; Huang X; Wang H
BMC Mol Cell Biol; 2022 Jul; 23(1):34. PubMed ID: 35896973
[TBL] [Abstract][Full Text] [Related]
24. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
[TBL] [Abstract][Full Text] [Related]
25. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
Song K; Yu P; Zhang C; Yuan Z; Zhang H
Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
[TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway.
Ren M; Wang T; Han Z; Fu P; Liu Z; Ouyang C
J Cardiovasc Pharmacol; 2020 Nov; 76(5):635-644. PubMed ID: 32833899
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.
Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y
Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015
[TBL] [Abstract][Full Text] [Related]
28. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
29. Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy.
Jiang T; Zhu J; Jiang S; Chen Z; Xu P; Gong R; Zhong C; Cheng Y; Sun X; Yi W; Yang J; Zhou W; Cheng Y
Adv Sci (Weinh); 2023 Jun; 10(17):e2207257. PubMed ID: 37096846
[TBL] [Abstract][Full Text] [Related]
30. miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.
Liu P; Tang H; Chen B; He Z; Deng M; Wu M; Liu X; Yang L; Ye F; Xie X
Cancer Lett; 2015 Feb; 357(1):384-392. PubMed ID: 25434799
[TBL] [Abstract][Full Text] [Related]
31. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
[TBL] [Abstract][Full Text] [Related]
32. Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via
Lu Q; Chen W; Ji Y; Liu Y; Xue X
Cancer Biother Radiopharm; 2022 Oct; 37(8):673-683. PubMed ID: 33493421
[No Abstract] [Full Text] [Related]
33. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer.
Zhang X; Li F; Zhou Y; Mao F; Lin Y; Shen S; Li Y; Zhang S; Sun Q
Cell Death Dis; 2021 Jun; 12(7):627. PubMed ID: 34145213
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA OIP5-AS1 aggravates acute lung injury by promoting inflammation and cell apoptosis via regulating the miR-26a-5p/TLR4 axis.
Sun Q; Luo M; Gao Z; Han X; Wu W; Zhao H
BMC Pulm Med; 2021 Jul; 21(1):236. PubMed ID: 34261477
[TBL] [Abstract][Full Text] [Related]
36. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Vishnubalaji R; Alajez NM
Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
[TBL] [Abstract][Full Text] [Related]
38. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
39. LncRNA-ZNF252P-AS1/miR-15b-5p promotes the proliferation of keloid fibroblast by regulating the BTF3-STAT3 signaling pathway.
Guo Y; Li M; Long J; Fan P; Zuo C; Wang Y
J Dermatol Sci; 2022 Dec; 108(3):146-156. PubMed ID: 36641250
[TBL] [Abstract][Full Text] [Related]
40. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
Wu EY; Huang LP; Bao JH
Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
